CINECA IRIS Institutional Research Information System

LANZOLLA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.623
AS - Asia 1.070
EU - Europa 790
SA - Sud America 197
AF - Africa 56
OC - Oceania 1
Totale 3.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.596
SG - Singapore 371
CN - Cina 266
HK - Hong Kong 201
SE - Svezia 182
IT - Italia 173
BR - Brasile 166
DE - Germania 126
VN - Vietnam 72
FR - Francia 58
GB - Regno Unito 54
BG - Bulgaria 46
AT - Austria 36
FI - Finlandia 33
IN - India 33
JP - Giappone 32
RU - Federazione Russa 24
TR - Turchia 24
CI - Costa d'Avorio 20
SN - Senegal 14
BD - Bangladesh 13
IQ - Iraq 13
CA - Canada 12
ZA - Sudafrica 11
UA - Ucraina 10
SA - Arabia Saudita 9
NL - Olanda 8
PL - Polonia 8
AR - Argentina 7
ES - Italia 7
MX - Messico 6
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 5
BE - Belgio 4
EG - Egitto 4
IE - Irlanda 4
JO - Giordania 4
PY - Paraguay 4
AZ - Azerbaigian 3
EC - Ecuador 3
MA - Marocco 3
PK - Pakistan 3
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
ID - Indonesia 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 3.737
Salva come PNG Salva come JPEG
Città #
Dallas 371
Ashburn 205
Hong Kong 199
Singapore 195
Santa Clara 122
Chandler 107
Fairfield 85
Shanghai 68
Beijing 66
Munich 55
New York 55
Sofia 46
Los Angeles 45
Seattle 43
Woodbridge 42
Boardman 38
Florence 36
Wilmington 36
Vienna 31
Houston 28
London 28
Turku 27
Bremen 24
Marseille 23
Tokyo 23
Frankfurt am Main 22
Abidjan 20
Ho Chi Minh City 20
Lawrence 20
Princeton 20
Pisa 17
Cambridge 16
Istanbul 16
Hanoi 15
Medford 15
Dakar 14
Rome 14
Ann Arbor 12
Redondo Beach 12
Düsseldorf 11
Lucca 11
Chicago 10
Denver 10
Atlanta 9
Buffalo 9
San Diego 9
São Paulo 9
Vicopisano 9
Ogden 8
Baghdad 7
Brooklyn 7
Chennai 7
Dong Ket 7
Johannesburg 7
Poplar 7
Boston 6
Cagliari 6
Fuzhou 6
Nuremberg 6
Amsterdam 5
Cascina 5
Guangzhou 5
Helsinki 5
Livorno 5
Mexico City 5
Milan 5
Rio de Janeiro 5
San Francisco 5
Serra 5
Warsaw 5
Zhengzhou 5
Amman 4
Belo Horizonte 4
Brussels 4
Caracas 4
Elk Grove Village 4
Jeddah 4
Manchester 4
Miami 4
Montreal 4
Norwalk 4
Ossé 4
Quanzhou 4
Tashkent 4
Ankara 3
Baku 3
Basra 3
Campinas 3
Canoas 3
Da Nang 3
Des Moines 3
Dhaka 3
Dublin 3
Genoa 3
Ha Long 3
João Pessoa 3
Juiz de Fora 3
Kent 3
Kocaeli 3
Osaka 3
Totale 2.552
Salva come PNG Salva come JPEG
Nome #
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 169
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 158
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 156
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 151
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 149
Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome 133
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 133
null 120
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols 108
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules 102
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease 102
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 101
null 85
Sirolimus as a second-line treatment for Graves' orbitopathy 84
Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy 83
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study 80
null 80
null 77
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 72
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 72
IgG4 serum levels in Graves' orbitopathy 69
Long-term outcome of Graves’ orbitopathy following treatment with sirolimus 69
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 68
null 68
Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study 67
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study 65
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) 63
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 62
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy 61
Antioxidant Therapy in Graves’ Orbitopathy 61
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 59
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study 57
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 57
null 57
IgG4 serum levels in Graves' orbitopathy 53
Absence of a relationship between vitamin D and Graves’ orbitopathy 52
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 52
Genetic Profiling of Orbital Fibroblasts from Patients with Graves’ Orbitopathy 50
Graves disease: latest understanding of pathogenesis and treatment options 47
null 43
Absence of a relationship between vitamin D and Graves’ orbitopathy 42
Statins in Graves Orbitopathy: A New Therapeutic Tool 41
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy 40
Statins in Graves Orbitopathy: A New Therapeutic Tool 39
null 37
null 35
Graves’ disease and Graves’ orbitopathy following COVID-19 31
null 30
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy 26
Statins: A New Hope on the Horizon of Graves Orbitopathy? 25
Oxidative Stress in Graves Disease and Graves Orbitopathy 24
Oxidative Stress in Graves Disease and Graves Orbitopathy 15
Statins: A New Hope on the Horizon of Graves Orbitopathy? 15
null 3
Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study) 3
null 1
null 1
null 1
Totale 3.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 17 9 19 13 22 18
2021/2022284 0 2 1 25 60 38 7 8 40 47 12 44
2022/2023470 48 77 49 36 36 48 2 30 92 5 43 4
2023/2024200 4 18 17 14 18 45 17 7 2 4 30 24
2024/20251.276 11 33 22 45 98 143 110 56 129 134 158 337
2025/20261.233 154 262 362 216 224 15 0 0 0 0 0 0
Totale 3.804